Northlane Capital Partners Invests in SAI MedPartners
June 7, 2022
Northlane Capital Partners has made an investment in SAI MedPartners, a life-sciences consultancy providing competitive intelligence, strategy, and analytics to pharmaceutical, biotechnology, and medical device companies. The investment, made in partnership with SAI management led by Founder and CEO Erik Nordhoy, will support expansion of SAI's service offerings and global growth. SAI is headquartered in Reading, Pennsylvania and has more than 180 employees across the United States, Europe, and Asia.
- Buyers
- Northlane Capital Partners
- Targets
- SAI MedPartners
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SAI MedPartners Acquires The Dunn Group
December 4, 2025
Healthcare Services
SAI MedPartners, a Northlane Capital Partners-backed healthcare consultancy, has acquired The Dunn Group, a Totowa, New Jersey-based competitive intelligence firm focused on pharmaceuticals, biotechnology, and medical devices. The acquisition expands SAI's competitive intelligence capabilities and deepens its life sciences market research and analytics offerings.
-
SAI MedPartners Acquires IDEA Pharma
November 14, 2024
Healthcare Services
SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.
-
SAI MedPartners Acquires PharmaForce International
March 29, 2023
Healthcare Services
SAI MedPartners, a consultancy focused on strategic insights and analytics for the pharmaceutical, biotech, and medical device industries, has acquired PharmaForce International, a Reading, Pennsylvania–based market intelligence and syndicated research firm. The acquisition adds PharmaForce's commercial benchmarking and syndicated research capabilities to SAI's competitive intelligence offerings; SAI is PE-backed by Northlane Capital Partners (which partnered with management to acquire SAI in June 2022).
-
SAI MedPartners Acquires Fulcrum Research Group
January 4, 2023
Healthcare Services
SAI MedPartners, a consultancy backed by Northlane Capital Partners, has acquired Fulcrum Research Group, a Waltham, MA-based primary market research firm focused on healthcare and biopharma. The add-on expands SAI's strategic insights and primary research capabilities to better serve pharmaceutical, biotechnology, and medical device clients.
-
Northlane Capital Partners Acquires Majority Stake in Infobase
June 15, 2022
Education
Northlane Capital Partners has made a majority investment in Infobase, a New York–based provider of cloud-based educational content and learning platforms. Centre Lane Partners and Infobase management retain significant continued equity, and NCP will support Infobase's growth and M&A initiatives to expand its position in K–12, higher education and corporate learning markets.
-
Enhanced Healthcare Partners & Bourne Partners Strategic Capital Acquire Pharmaceutical Associates, Inc.
November 6, 2019
Pharmaceuticals
Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.